Dermatology · 2008 · 56 citations · 20 references
MedicineDermatologyPharmacologyHypersensitivityPharmacogeneticsPharmacogenomicsDrug DispositionDrug Metabolism GeneticsDrug-induced Skin ReactionsDress SyndromeDrug-induced Rash With EosinophiliaDrug-induced Skin EruptionsEosinophilic DermatosesEosinophilic Skin DisordersGenetic PolymorphismsGlutathione S-transferasesMinocycline Therapy
BACKGROUND: Minocycline-induced drug rash with eosinophilia and systemic symptoms (DRESS) may have a prolonged course, especially in African and African-American patients. OBJECTIVES: To determine if a prolonged course of minocycline-induced DRESS was associated with an accumulation of the culprit drug. PATIENTS AND METHODS: We determined plasma and skin levels of minocycline in patients with minocycline-induced DRESS. We investigated the genetic polymorphisms of enzymes potentially involved in the detoxification of the drug, glutathione S-transferases and UDP-glucuronosyltransferases. RESULTS AND CONCLUSIONS: We demonstrated the persistence of minocycline in the plasma and/or in the skin of 7 out of 9 patients with skin phototypes V-VI. As pigmented skin contains more melanin, this could promote the formation of a melanin-minocycline complex, which could explain the severe and prolonged DRESS which may occur in this subgroup of patients.
20
Metabolic gene polymorphism frequencies in control populations.
Seymour Garte, Laura Gaspari, Anna-Karin Alexandrie et al. · PubMed · 2001 · 847 citations
Yukio Ando, Hideo Saka, Maki Ando et al. · PubMed · 2000 · 788 citations
Medicine, Genetics, Pharmacology +15
Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome
I. García‐Doval, Laurence Le Cleach, Hélène Bocquet et al. · Archives of Dermatology · 2000 · 493 citations